Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 33.61B | 41.82B | 21.04B | 16.44B | 10.58B | 7.14B |
Gross Profit | 4.70B | 5.65B | 3.56B | 2.21B | 1.55B | 1.17B |
EBITDA | 1.44B | 2.01B | 1.04B | 609.73M | 372.49M | 219.95M |
Net Income | 1.01B | 1.35B | 647.57M | 336.17M | 172.42M | 50.23M |
Balance Sheet | ||||||
Total Assets | 47.87B | 52.94B | 35.75B | 21.49B | 10.93B | 9.05B |
Cash, Cash Equivalents and Short-Term Investments | 7.88B | 19.21B | 9.54B | 6.20B | 1.46B | 2.04B |
Total Debt | 7.94B | 4.76B | 5.94B | 3.03B | 1.18B | 2.27B |
Total Liabilities | 43.19B | 47.66B | 31.94B | 18.38B | 9.88B | 8.17B |
Stockholders Equity | 4.68B | 5.27B | 3.81B | 3.11B | 1.04B | 871.30M |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 10.96B | -1.26B | 1.27B | 196.17M | -745.75M |
Operating Cash Flow | 0.00 | 10.98B | -1.21B | 1.29B | 274.83M | -513.92M |
Investing Cash Flow | 0.00 | -1.17B | -134.78M | -122.80M | 237.44M | -239.15M |
Financing Cash Flow | 0.00 | -1.11B | 2.91B | 3.57B | -1.09B | 1.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | ¥15.30B | 31.28 | 2.79% | -4.73% | -51.89% | ||
63 Neutral | ¥43.46B | 120.70 | ― | -6.47% | -13.48% | ||
61 Neutral | ¥28.35B | 20.66 | 0.64% | 98.73% | 104.12% | ||
61 Neutral | ¥14.92B | 10.21 | 6.39% | 22.01% | 26.92% | ||
58 Neutral | HK$90.97B | 5.09 | -3.21% | 5.32% | 7.36% | -55.21% | |
53 Neutral | ¥19.16B | 17.36 | 2.00% | -36.03% | -39.34% | ||
33 Underperform | ¥21.55B | 119.43 | 27.83% | 24.41% | -108.84% |